Today is an exceptionally significant day for me, both personally and professionally.
A study conducted at the University of Oulu, in which the Neurosonic technology I developed was part of the research intervention, has been published in Nature Communications, a highly respected international scientific journal.
Being published in a scientific journal of this calibre within the Nature Portfolio family is a tremendous achievement. To me, it means more than I can put into words.
When I began developing Neurosonic, I had a strong conviction that precisely controlled mechanical vibration applied to the body could influence human physiological regulation and wellbeing in ways we do not yet fully understand.
Over the years, I have heard thousands of accounts of Neurosonic's effects. What has stayed with me in particular are clients' descriptions of how, after a session, their thoughts flow more clearly, their brain feels lighter and even their vision seems sharper.
These experiences have been important observations for me, and they have encouraged me to look for the physiological mechanisms behind them.
Now we have significant new research findings.
The University of Oulu study found that a combination of a treatment affecting blood vessel function and mechanical whole-body vibration increased the transfer of certain brain-derived proteins into the bloodstream, including amyloid beta 40 and 42, which are associated with Alzheimer's disease.
The finding opens interesting new perspectives for research into brain fluid circulation, the clearance of metabolic products and brain health.
It is important to note that the study examined a combined intervention. Based on it, it is not yet possible to draw conclusions about the independent effect of Neurosonic, or to demonstrate the prevention or treatment of Alzheimer's disease.
Even so, the study is a significant step towards understanding the mechanisms I have been working to uncover for years.
I would like to express my especially warm thanks to the study's lead researcher, Johanna Tuunanen, and to Professor Vesa Kiviniemi.
Their scientific expertise, perseverance and courage to investigate new kinds of physiological phenomena have made this achievement possible.
I also thank the entire research group and everyone who, over the years, has believed in Neurosonic's potential.
As a developer and a psychotherapist, I have always been particularly interested in the connection between body and mind. This study strengthens my view of how important it is to study the human being as a whole.
Today, above all, I feel deep gratitude, joy and pride.
It is a great honour to see my life's work be part of research published in one of the world's most respected scientific journal series.
This is not the end of the research journey. I believe we are only at the beginning of a new and highly interesting field of research.
Marco Kärkkäinen
Developer of the Neurosonic method
Psychotherapist
Study: Vasomechanic treatment increases efflux of human brain proteins, Nature Communications
